This contrasts with RPS6KB1, which shows elevated expression in cholangiocarcinoma, diffuse large B-cell lymphoma (DLBCL), and thymoma (THYM) (Figure 6B). Here, RPS6KB1 is linked to diffuse large B-cell lymphoma.